Search research articles
Contact Us
Filters
Showing results (1-10 of 68) with videos related to
Page
of 7
Sort By:
Blood
|
November 21, 2015
Is there a best TKI for chronic phase CML?
Richard A Larson
Blood
|
June 12, 2010
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm
Roland B Walter, Frederick R Appelbaum, Martin S Tallman, et al.
Blood
|
August 17, 2004
Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628
Madhav V Dhodapkar, Mohamad A Hussein, Erik Rasmussen, et al.
Blood
|
May 27, 2008
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock, Mei La, Ben Sanford, et al.
Blood
|
February 8, 2008
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
Richard A Larson, Brian J Druker, Francois Guilhot, et al.
Blood
|
April 22, 2006
Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials
Lydia Roy, Joëlle Guilhot, Tillmann Krahnke, et al.
Blood
|
February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511
Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
Blood
|
April 23, 2008
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility
Nathan A Ellis, Dezheng Huo, Ozlem Yildiz, et al.
Blood
|
March 8, 2003
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
Sonali M Smith, Michelle M Le Beau, Dezheng Huo, et al.
Blood
|
October 24, 2002
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
John C Byrd, Bercedis L Peterson, Vicki A Morrison, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 68) with videos related to
Sort By:
Page
of 7
Blood
|
November 21, 2015
Is there a best TKI for chronic phase CML?
Richard A Larson
Blood
|
June 12, 2010
Shortcomings in the clinical evaluation of new drugs: acute myeloid leukemia as paradigm
Roland B Walter, Frederick R Appelbaum, Martin S Tallman, et al.
Blood
|
August 17, 2004
Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628
Madhav V Dhodapkar, Mohamad A Hussein, Erik Rasmussen, et al.
Blood
|
May 27, 2008
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock, Mei La, Ben Sanford, et al.
Blood
|
February 8, 2008
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
Richard A Larson, Brian J Druker, Francois Guilhot, et al.
Blood
|
April 22, 2006
Survival advantage from imatinib compared with the combination interferon-alpha plus cytarabine in chronic-phase chronic myelogenous leukemia: historical comparison between two phase 3 trials
Lydia Roy, Joëlle Guilhot, Tillmann Krahnke, et al.
Blood
|
February 1, 2007
Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511
Meir Wetzler, Ben L Sanford, Joanne Kurtzberg, et al.
Blood
|
April 23, 2008
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility
Nathan A Ellis, Dezheng Huo, Ozlem Yildiz, et al.
Blood
|
March 8, 2003
Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series
Sonali M Smith, Michelle M Le Beau, Dezheng Huo, et al.
Blood
|
October 24, 2002
Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: results from Cancer and Leukemia Group B 9712 (CALGB 9712)
John C Byrd, Bercedis L Peterson, Vicki A Morrison, et al.
Page
of 7